Clinical trial
LANCGMS - Lantus Continuous Glucose Monitoring Subcutaneous
NCT00322075 · Sanofi, Industry · Completed
Key facts
| NCT number | NCT00322075 |
|---|---|
| Title | LANCGMS - Lantus Continuous Glucose Monitoring Subcutaneous |
| Official title | Comparison of Glycaemic Fluctuations During 3 Days Subcutaneous Continuous Monitoring in Patients With Basal Substitution Human Insulin NPH vs Insuline Glargine |
| Lead sponsor | Sanofi, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | insulin glargine |
| Enrollment | 35 |
| Start date | Apr 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | May 4, 2006 |
| Last update posted | Sep 12, 2007 |
| Countries | Czechia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: